Location History:
- Alabaster, AL (US) (2011 - 2017)
- Birmingham, AL (US) (2021)
Company Filing History:
3 out of 2,009 
3 out of 276 
1 out of 15,475 
Years Active: 2011-2021
Title: Julie Decker: Innovator in Immunogen Research
Introduction
Julie Decker is a prominent inventor based in Alabaster, Alabama, known for her significant contributions to the field of immunogen research. With a total of four patents to her name, she has made strides in developing innovative solutions for combating HIV.
Latest Patents
Her latest patents include groundbreaking work on consensus and ancestral immunogens. This invention focuses on an immunogen designed to induce antibodies that neutralize a wide spectrum of HIV primary isolates. Additionally, it aims to stimulate a T cell immune response. The invention also encompasses methods for inducing anti-HIV antibodies and T cell immune responses using these immunogens. Another notable patent involves modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins, which are capable of inducing broadly reactive T- and B-cell responses.
Career Highlights
Throughout her career, Julie Decker has worked with esteemed institutions such as Duke University and the University of Alabama. Her research has been pivotal in advancing the understanding of HIV and developing potential therapeutic strategies.
Collaborations
Julie has collaborated with notable researchers, including Beatrice H. Hahn and George M. Shaw, further enhancing the impact of her work in the scientific community.
Conclusion
Julie Decker's innovative research and patents in immunogen development highlight her dedication to addressing critical health challenges. Her contributions continue to influence the field of immunology and offer hope for advancements in HIV treatment.